TRIAMCINOLONE

Triamcinolone Adverse Events Reported to the FDA Over Time

How are Triamcinolone adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Triamcinolone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Triamcinolone is flagged as the suspect drug causing the adverse event.

Most Common Triamcinolone Adverse Events Reported to the FDA

What are the most common Triamcinolone adverse events reported to the FDA?

Blood Glucose Increased	1035 (4.12%)
Blood Glucose Decreased	499 (1.99%)
Drug Ineffective	390 (1.55%)
Drug Exposure During Pregnancy	362 (1.44%)
Hypoglycaemia	344 (1.37%)
Dyspnoea	280 (1.12%)
Loss Of Consciousness	263 (1.05%)
Visual Acuity Reduced	245 (.98%)
Dizziness	199 (.79%)
Fall	191 (.76%)
Nausea	188 (.75%)
	Show More
Cerebrovascular Accident	183 (.73%)
Blood Glucose Fluctuation	182 (.73%)
Vomiting	169 (.67%)
Blindness	165 (.66%)
Malaise	164 (.65%)
Myocardial Infarction	160 (.64%)
Headache	159 (.63%)
Asthenia	143 (.57%)
Hyperglycaemia	140 (.56%)
Feeling Abnormal	139 (.55%)
Pain In Extremity	135 (.54%)
Cataract	134 (.53%)
Diabetes Mellitus Inadequate Contro...	129 (.51%)
Weight Decreased	125 (.5%)
Fatigue	122 (.49%)
Cardiac Disorder	120 (.48%)
Convulsion	114 (.45%)
Renal Failure	110 (.44%)
Pyrexia	109 (.43%)
Incorrect Dose Administered	107 (.43%)
Hypertension	106 (.42%)
Pain	106 (.42%)
Diarrhoea	102 (.41%)
Oedema Peripheral	101 (.4%)
Hospitalisation	99 (.39%)
Death	97 (.39%)
Eye Haemorrhage	97 (.39%)
Hypersensitivity	97 (.39%)
Cardiac Failure Congestive	96 (.38%)
Medication Error	96 (.38%)
Weight Increased	95 (.38%)
Confusional State	94 (.37%)
Tremor	94 (.37%)
Hyperhidrosis	93 (.37%)
Pruritus	93 (.37%)
Chest Pain	92 (.37%)
Rash	90 (.36%)
Syncope	87 (.35%)
Pneumonia	86 (.34%)
Drug Hypersensitivity	85 (.34%)
Hypoglycaemic Unconsciousness	84 (.33%)
Memory Impairment	83 (.33%)
Premature Baby	81 (.32%)
Arthralgia	77 (.31%)
Insomnia	77 (.31%)
Vision Blurred	76 (.3%)
Visual Impairment	76 (.3%)
Gait Disturbance	74 (.29%)
Asthma	73 (.29%)
Suicide Attempt	73 (.29%)
Anti-insulin Antibody Positive	72 (.29%)
Urticaria	72 (.29%)
Glycosylated Haemoglobin Increased	71 (.28%)
Road Traffic Accident	70 (.28%)
Depression	69 (.27%)
Blindness Unilateral	68 (.27%)
Arthritis	67 (.27%)
Drug Dose Omission	67 (.27%)
Abortion Spontaneous	66 (.26%)
Condition Aggravated	66 (.26%)
Coma	64 (.26%)
Hepatic Function Abnormal	64 (.26%)
Alanine Aminotransferase Increased	62 (.25%)
Back Pain	62 (.25%)
Blood Pressure Decreased	62 (.25%)
Blood Pressure Increased	62 (.25%)
Drug Interaction	62 (.25%)
Overdose	62 (.25%)
Aspartate Aminotransferase Increase...	61 (.24%)
Glaucoma	61 (.24%)
Injection Site Pain	61 (.24%)
Infection	60 (.24%)
Cardiac Arrest	58 (.23%)
Diabetic Ketoacidosis	57 (.23%)
Diabetic Retinopathy	57 (.23%)
Retinal Detachment	57 (.23%)
Urinary Tract Infection	57 (.23%)
Abdominal Pain	56 (.22%)
Renal Disorder	54 (.22%)
Cough	53 (.21%)
Hypoaesthesia	53 (.21%)
Paraesthesia	53 (.21%)
Product Quality Issue	52 (.21%)
Abdominal Pain Upper	51 (.2%)
Dehydration	51 (.2%)
Intentional Overdose	51 (.2%)
Wrong Drug Administered	51 (.2%)
Anxiety	50 (.2%)
Blood Glucose Abnormal	50 (.2%)
Depressed Level Of Consciousness	50 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Triamcinolone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triamcinolone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Triamcinolone

What are the most common Triamcinolone adverse events reported to the FDA?

Metabolic, Nutritional And Blood Ga...	1869 (7.45%)
Neurological	1299 (5.18%)
Glucose Metabolism Disorders	842 (3.36%)
Medication Errors	729 (2.91%)
Vision	710 (2.83%)
Respiratory	691 (2.75%)
Infections - Pathogen Unspecified	676 (2.69%)
Epidermal And Dermal Conditions	654 (2.61%)
Gastrointestinal Signs	599 (2.39%)
Therapeutic And Nontherapeutic Effe...	591 (2.36%)
Injuries	550 (2.19%)
	Show More
Chemical Injury And Poisoning	402 (1.6%)
Administration Site Reactions	368 (1.47%)
Musculoskeletal And Connective Tiss...	342 (1.36%)
Allergic Conditions	289 (1.15%)
Cardiac And Vascular Investigations	289 (1.15%)
Cardiac Arrhythmias	278 (1.11%)
Central Nervous System Vascular	278 (1.11%)
Physical Examination Topics	270 (1.08%)
Joint	260 (1.04%)
Renal Disorders	257 (1.02%)
Coronary Artery	254 (1.01%)
Procedural And Device Related Injur...	227 (.9%)
Bone And Joint Injuries	220 (.88%)
Hepatic And Hepatobiliary	220 (.88%)
Ocular Structural Change, Deposit A...	214 (.85%)
Movement Disorders	205 (.82%)
Anxiety Disorders	197 (.79%)
Mental Impairment	195 (.78%)
Hepatobiliary	193 (.77%)
Hematology Investigations	187 (.75%)
Cardiac Disorder Signs	185 (.74%)
Therapeutic Procedures And Supporti...	182 (.73%)
Skin Appendage Conditions	181 (.72%)
Anterior Eye Structural Change, Dep...	179 (.71%)
Muscle	175 (.7%)
Gastrointestinal Motility And Defec...	174 (.69%)
Headaches	174 (.69%)
Retina, Choroid And Vitreous Hemorr...	173 (.69%)
Bacterial Infectious	172 (.69%)
Immunology And Allergy	166 (.66%)
Eye	162 (.65%)
Bronchial Disorders	159 (.63%)
Electrolyte And Fluid Balance Condi...	157 (.63%)
Ocular Infections, Irritations And ...	149 (.59%)
Heart Failures	148 (.59%)
Deliria	139 (.55%)
Seizures	135 (.54%)
Viral Infectious	130 (.52%)
Appetite And General Nutritional	129 (.51%)
Suicidal And Self-injurious Behavio...	129 (.51%)
Neonatal And Perinatal Conditions	127 (.51%)
Fatal Outcomes	126 (.5%)
Body Temperature Conditions	124 (.49%)
Bone And Joint Therapeutic Procedur...	120 (.48%)
Ocular Hemorrhages And Vascular	120 (.48%)
Vascular Hypertensive	119 (.47%)
Abortions And Stillbirth	118 (.47%)
Decreased And Nonspecific Blood Pre...	114 (.45%)
Sleep Disorders	114 (.45%)
Peripheral Neuropathies	113 (.45%)
Arteriosclerosis, Stenosis, Vascula...	110 (.44%)
Lifestyle Issues	106 (.42%)
Oral Soft Tissue Conditions	104 (.41%)
Psychiatric	96 (.38%)
Upper Respiratory Tract Disorders	92 (.37%)
Angiedema And Urticaria	90 (.36%)
Glaucoma And Ocular Hypertension	90 (.36%)
Lower Respiratory Tract Disorders	90 (.36%)
Disturbances In Thinking	87 (.35%)
Product Quality Issues	87 (.35%)
Diabetic Complications	83 (.33%)
Cardiac Therapeutic Procedures	82 (.33%)
Vascular	81 (.32%)
Depressed Mood Disorders	80 (.32%)
Bone Disorders	79 (.31%)
Musculoskeletal And Connective Tiss...	77 (.31%)
Embolism And Thrombosis	76 (.3%)
Eye Therapeutic Procedures	76 (.3%)
Urinary Tract Signs	68 (.27%)
Renal And Urinary Tract Investigati...	65 (.26%)
Spinal Cord And Nerve Root	65 (.26%)
Water, Electrolyte And Mineral	65 (.26%)
Adrenal Gland	64 (.26%)
Anemias Nonhemolytic And Marrow Dep...	64 (.26%)
Enzyme	61 (.24%)
Hearing	60 (.24%)
Mood Disorders	60 (.24%)
Tissue	60 (.24%)
Vascular Therapeutic Procedures	59 (.24%)
Neurological, Special Senses And Ps...	56 (.22%)
Skin And Subcutaneous Tissue	56 (.22%)
Ocular Neuromuscular	54 (.22%)
Gastrointestinal Neoplasms Malignan...	50 (.2%)
Microbiology And Serology	50 (.2%)
Exocrine Pancreas Conditions	49 (.2%)
Fungal Infectious	48 (.19%)
Cranial Nerve Disorders	47 (.19%)
Personality Disorders	45 (.18%)
Miscellaneous And Site Unspecified ...	44 (.18%)
Myocardial	44 (.18%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Triamcinolone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Triamcinolone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.